Your browser doesn't support javascript.
loading
A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.
Vanderweil, Stefan G; Amano, Shinya; Ko, Wei-Che; Richmond, Jillian M; Kelley, Michelle; Senna, Maryanne Makredes; Pearson, Andrea; Chowdary, Sandhya; Hartigan, Celia; Barton, Bruce; Harris, John E.
Afiliación
  • Vanderweil SG; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Amano S; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Ko WC; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Richmond JM; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Kelley M; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Senna MM; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Pearson A; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Chowdary S; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Hartigan C; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Barton B; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Harris JE; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA. Electronic address: john.harris@umassmed.edu.
J Am Acad Dermatol ; 76(1): 150-151.e3, 2017 Jan.
Article en En | MEDLINE | ID: mdl-27986135
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vitíligo / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Simvastatina Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Año: 2017 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vitíligo / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Simvastatina Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Año: 2017 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Estados Unidos